Allen, DB ;
Backeljauw, P ;
Bidlingmaier, M...
Allen , DB , Backeljauw , P , Bidlingmaier , M , Biller , BMK , Boguszewski , M , Burman , P , Butler , G , Chihara , K , Christiansen , J , Cianfarani , S , Clayton , P , Clemmons , D , Cohen , P , Darendeliler , F , Deal , C , Dunger , D , Erfurth , EM , Fuqua , JS , Grimberg , A , Haymond , M , Higham , C , Ho , K , Hoffman , AR , Hokken - Koelega , A , Johannsson , G , Juul , A , Kopchick , J , Lee , P , Pollak , M , Radovick , S , Robison , L , Rosenfeld , R , Ross , RJ , Savendahl , L , Saenger , P , Sorensen , HT , Stochholm , K , Strasburger , C , Swerdlow , A & Thorner , M 2016 , ' GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults ' , European Journal of Endocrinology , vol. 174 , no. 2 , pp. P1-P9 . https://doi.org/10.1530/EJE-15-0873.
,
2016